Inmed to discuss its pharmaceutical pipeline and 2024 strategic priorities in fireside chat with water tower research on january 25, 2024 at 1pm et

Vancouver, british columbia--(newsfile corp. - january 18, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, will be participating in the water tower research fireside chat series on january 25, 2024, at 1:00 pm et. this event is open access for all investors.
INM Ratings Summary
INM Quant Ranking